CD4 and neoplasm: For example, CD4 + T cell-derived EVs enriched with pro-inflammatory cytokines such as IFNγ, TNFα and IL-2, are taken up by macrophages to sustain M1 anti-tumor phenotype and to stimulate cGAS-independent STING activation, subsequently inhibiting CRC progression [231].